Basal-bolus regimen versus twice-daily premixed insulin in the treatment of childhood type 1 diabetes mellitus in Mosul City: A comparison study
Problems of Endocrinology · 07.03.2026 · 72 (1) · 108-114
DOI: 10.14341/probl13609 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Problems of Endocrinology, online erschienen am 07.03.2026. Verfasst von I A Mohialdeen und 1 weiteren Autor:innen. Beteiligte Einrichtung: AL-Khansaa Maternity and Children Teaching Hospital. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Insulin, Hypoglycemic Agents. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUND: Type 1 diabetes mellitus is the most common endocrine-metabolic disorder in childhood and adolescence. Some families may find it difficult to administer four daily injections, especially in young children, or to use the newer, expensive insulin analogs and pumps. For this reason, many physicians are still using the classical two-injection schedule, using premixed insulin in certain areas of the world. AIM: To assess glycemic control and complication indicators in type 1 diabetic children on premixed or basal-bolus insulin. METHODS: One hundred children aged 2–14 years with type 1 diabetes mellitus were studied at multiple diabetes care centers; fifty were receiving premixed insulin, and the other fifty were on a basal-bolus insulin regimen. Evaluations were made based on HbA 1c levels, occurrences of hypoglycemia, ketoacidosis, and other complications. RESULTS: The study revealed significant improvements in HbA 1c levels in the basal-bolus insulin group compared to premixed insulin patients three and six months after treatment (p=0.048 and p=0.005, respectively). Patients using the premixed regimen experienced more frequent hypoglycemia attacks (p=0.001) and injection site complications, such as hypertrophy (p=0.001). CONCLUSIONS: It has been revealed that a basal-bolus regimen (MDI) improves children’s and teenagers’ glycemic control with fewer complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- AL-Khansaa Maternity and Children Teaching Hospital.
- University of Mosul, College of Medicine.
Zitieren
APA
Mohialdeen, I. A., & Al-Numan, A. H. (2026). Basal-bolus regimen versus twice-daily premixed insulin in the treatment of childhood type 1 diabetes mellitus in Mosul City: A comparison study. Problems of Endocrinology, 72(1), 108-114. https://doi.org/10.14341/probl13609
Vancouver
Mohialdeen IA, Al-Numan AH. Basal-bolus regimen versus twice-daily premixed insulin in the treatment of childhood type 1 diabetes mellitus in Mosul City: A comparison study. Problems of Endocrinology. 2026;72(1):108-114. doi:10.14341/probl13609
BibTeX
@article{Mohialdeen2026,
author = {Mohialdeen, I A and Al-Numan, A H},
title = {Basal-bolus regimen versus twice-daily premixed insulin in the treatment of childhood type 1 diabetes mellitus in Mosul City: A comparison study},
journal = {Problems of Endocrinology},
year = {2026},
volume = {72},
number = {1},
pages = {108--114},
doi = {10.14341/probl13609}
}
EUVIMED